'Discovery void' in the development of antibiotics

A report from the Government's Chief Medical Officer has highlighted a "discovery void" in the development of antibiotics since 1987.

It said that pharmaceutical companies need to be incentivised to develop new antibiotics.

We have also been waiting for the next new antibiotic to come along and treat those resistant cases but the pipeline is drying up.

There are no new classes of antibiotics in the pipelines across the world and there are very few in development.

That's because we have not, as a global society, incentivised producing antibiotics. We have market failure and we really need to do something about this.

– Dame Sally Davies, Government's Chief Medical Officer